TELEVISED AGGRESSION AND CHILDREN\u27S SOCIAL BEHAVIOR: RELATIONSHIP OF AUTHENTICITY AND ADULT APPROVAL OF VIEWED BEHAVIOR TO CHILDREN\u27S AGGRESSION.

Television is nearly universal and young children are among the prime viewers. Citizens are concerned that television with its high rate of violence may be a more important guide to behavior than parents or teachers. This study investigates the effects on children\u27s behavior of viewed aggression varying both the level to which viewed actions are represented as authentic portrayals of real-life aggressive behavior and the level of approval for the portrayed behavior that is provided by an adult co-viewer. A critical review of the literature resulted in three hypotheses: increasing levels of authenticity and adult co-viewer approval associated with a portrayal of aggressive behavior interact to increase levels of children\u27s aggression as a result of the viewed presentation (Hypothesis I); levels of children\u27s aggressive behavior will decrease directly with decreasing levels of authenticity associated with viewed aggression (Hypothesis II); and levels of children\u27s aggressive behavior will decrease directly with decreasing levels of adult co-viewer approval expressed towards portrayals of aggression (Hypothesis III). A 3 x 2 factorial design was used. The first factor represents three levels of increasing adult co-viewer approval and the second represents two levels of authenticity of the scene. The subjects, 84 public school boys ranging in age from 10 to 13 years, were randomly assigned in equal numbers to one of the six experimental conditions. Each subject observed an aggressive scene on television while an adult co-viewer expressed either verbal approval, no comment, or verbal disapproval. These three conditions were combined with presentation of the scene with either a high or low level of authenticity (i.e., real or simulated aggression). Pre- and post-tests were conducted before and after the manipulation of the independent variables to obtain measures of each subject\u27s aggressiveness. Duration and frequency of button-pressing responses, through which a subject ostensibly could anonymously either help or interfere with a peer\u27s behavior were recorded. The procedure concluded with a post-experimental questionnaire which in part tested the validity of the experimental procedure and the impact of the independent variables. The data from the pre- and post-tests supported Hypothesis III. While the trends for Hypothesis I and Hypothesis II were in the predicted direction they were non-significant. It appears that the impact of televised aggression upon children\u27s behavior is highly dependent on adult co-viewer comments. Disapproving comments or approving comments tend to respectively decrease or increase children\u27s subsequent levels of aggression. Varying levels of authenticity had a marginal impact upon children\u27s reaction to the presentation but did not significantly interact with the approval variable. Previous studies which showed that varying the levels of authenticity of the viewed material affect children\u27s subsequent behavior, involved more salient modes of specifying authenticity and unlike the present study tested the impact of the presentation with obvious adult surveillance during testing. The present manipulation of the level of authenticity showed no significant effect and no interaction with the approval variable. This study suggests that televised violence should not be viewed as a threat to parental authority. When adults, perhaps unknowingly, indicate approval of violence, television may stimulate aggression. Adults who ignore television or see it as a baby-sitter, may be permitting haphazard factors to influence their children\u27s learning of social standards. Television, however, can be used by adults as an effective teaching tool. Parents can teach and reinforce their standards of behavior even with programming presenting contrary messages by showing their approval or disapproval of the programs.Dept. of Psychology. Paper copy at Leddy Library: Theses & Major Papers - Basement, West Bldg. / Call Number: Thesis1980 .G643. Source: Dissertation Abstracts International, Volume: 42-03, Section: B, page: 1231. Thesis (Ph.D.)--University of Windsor (Canada), 1981

Lithocholic bile acid selectively kills neuroblastoma cells, while sparing normal neuronal cells

Aging is one of the major risk factors of cancer. The onset of cancer can be postponed by pharmacological and dietary anti-aging interventions. We recently found in yeast cellular models of aging that lithocholic acid (LCA) extends longevity. Here we show that, at concentrations that are not cytotoxic to primary cultures of human neurons, LCA kills the neuroblastoma (NB) cell lines BE(2)-m17, SK-n-SH, SK-n-MCIXC and Lan-1. In BE(2)-m17, SK-n-SH and SK-n-MCIXC cells, the LCA anti-tumor effect is due to apoptotic cell death. In contrast, the LCA-triggered death of Lan-1 cells is not caused by apoptosis. While low concentrations of LCA sensitize BE(2)-m17 and SK-n-MCIXC cells to hydrogen peroxide-induced apoptotic cell death controlled by mitochondria, these LCA concentrations make primary cultures of human neurons resistant to such a form of cell death. LCA kills BE(2)-m17 and SK-n-MCIXC cell lines by triggering not only the intrinsic (mitochondrial) apoptotic cell death pathway driven by mitochondrial outer membrane permeabilization and initiator caspase-9 activation, but also the extrinsic (death receptor) pathway of apoptosis involving activation of the initiator caspase-8. Based on these data, we propose a mechanism underlying a potent and selective anti-tumor effect of LCA in cultured human NB cells. Moreover, our finding that LCA kills cultured human breast cancer and rat glioma cells implies that it has a broad anti-tumor effect on cancer cells derived from different tissues and organisms

Formal properties of recursive Virtual Machine architectures.

A formal model of hardware/software architectures is developed and applied to Virtual Machine Systems. Results are derived on the sufficient conditions that a machine architecture must verify in order to support VM systems. The model deals explicitly with resource mappings (protection) and with I/O devices. Some already published results are retrieved and other ones, more general, are obtained

A retrospective analysis of clinical use of alirocumab in lipoprotein apheresis patients

BACKGROUND: The previously published ODYSSEY ESCAPE trial demonstrated a significant reduction in the use of lipoprotein apheresis for heterozygous familial hypercholesterolemia (HeFH) patients when placed on alirocumab 150 mg every 2 weeks. In patients with HeFH who have consistently elevated levels of low-density lipoprotein cholesterol (LDL-C) despite maximally tolerated statin therapy, current lipid guidelines recommend apheresis. Although apheresis reduces LDL-C levels by 50%-75%, it must be repeated, as frequently as every 1-2 weeks. OBJECTIVE: To assess clinical experience with apheresis and alirocumab for patients in a real-world practice setting. METHODS: This retrospective review included patients from 5 apheresis centers who were treated with apheresis and had started alirocumab therapy. In addition to LDL-C levels, total cholesterol, high-density lipoprotein cholesterol (HDL-C), non-HDL-C, triglycerides, and particle numbers were evaluated if data were available. RESULTS: Eleven of the 25 (44%) patients discontinued apheresis completely after initiation of alirocumab therapy, having achieved LDL-C \u3c70 mg/dL or \u3e50% reduction from baseline levels. Among the 14 patients who remained on apheresis, seven decreased the frequency of apheresis sessions. No significant safety problems were reported. CONCLUSION: Alirocumab lowered LDL-C levels by an average of 55.5% in patients receiving apheresis for elevated LDL-C. Seventy-two percent of patients on alirocumab therapy discontinued or reduced the frequency of apheresis treatment. However, some patients continued to require apheresis due to elevated lipoprotein(a), extremely elevated LDL-C, or if alirocumab therapy was discontinued due to less than anticipated LDL-C reduction

Developing a Personality Model for Speech-based Conversational Agents Using the Psycholexical Approach

We present the first systematic analysis of personality dimensions developed specifically to describe the personality of speech-based conversational agents. Following the psycholexical approach from psychology, we first report on a new multi-method approach to collect potentially descriptive adjectives from 1) a free description task in an online survey (228 unique descriptors), 2) an interaction task in the lab (176 unique descriptors), and 3) a text analysis of 30,000 online reviews of conversational agents (Alexa, Google Assistant, Cortana) (383 unique descriptors). We aggregate the results into a set of 349 adjectives, which are then rated by 744 people in an online survey. A factor analysis reveals that the commonly used Big Five model for human personality does not adequately describe agent personality. As an initial step to developing a personality model, we propose alternative dimensions and discuss implications for the design of agent personalities, personality-aware personalisation, and future research.Comment: 14 pages, 2 figures, 3 tables, CHI'2

Teprotumumab for Thyroid-Associated Ophthalmopathy

BACKGROUND: Thyroid-associated ophthalmopathy, a condition commonly associated with Graves' disease, remains inadequately treated. Current medical therapies, which primarily consist of glucocorticoids, have limited efficacy and present safety concerns. Inhibition of the insulin-like growth factor I receptor (IGF-IR) is a new therapeutic strategy to attenuate the underlying autoimmune pathogenesis of ophthalmopathy. METHODS: We conducted a multicenter, double-masked, randomized, placebo-controlled trial to determine the efficacy and safety of teprotumumab, a human monoclonal antibody inhibitor of IGF-IR, in patients with active, moderate-to-severe ophthalmopathy. A total of 88 patients were randomly assigned to receive placebo or active drug administered intravenously once every 3 weeks for a total of eight infusions. The primary end point was the response in the study eye. This response was defined as a reduction of 2 points or more in the Clinical Activity Score (scores range from 0 to 7, with a score of ≥3 indicating active thyroid-associated ophthalmopathy) and a reduction of 2 mm or more in proptosis at week 24. Secondary end points, measured as continuous variables, included proptosis, the Clinical Activity Score, and results on the Graves' ophthalmopathy-specific quality-of-life questionnaire. Adverse events were assessed. RESULTS: In the intention-to-treat population, 29 of 42 patients who received teprotumumab (69%), as compared with 9 of 45 patients who received placebo (20%), had a response at week 24 (P<0.001). Therapeutic effects were rapid; at week 6, a total of 18 of 42 patients in the teprotumumab group (43%) and 2 of 45 patients in the placebo group (4%) had a response (P<0.001). Differences between the groups increased at subsequent time points. The only drug-related adverse event was hyperglycemia in patients with diabetes; this event was controlled by adjusting medication for diabetes. CONCLUSIONS: In patients with active ophthalmopathy, teprotumumab was more effective than placebo in reducing proptosis and the Clinical Activity Score. (Funded by River Vision Development and others; ClinicalTrials.gov number, NCT01868997 .)

Centromere Plasmid: A New Genetic Tool for the Study of Plasmodium falciparum

The introduction of transgenes into Plasmodium falciparum, a highly virulent human malaria parasite, has been conducted either by single crossover recombination or by using episomal plasmids. However, these techniques remain insufficient because of the low transfection efficiency and the low frequency of recombination. To improve the genetic manipulation of P. falciparum, we developed the centromere plasmid as a new genetic tool. First, we attempted to clone all of the predicted centromeres from P. falciparum into E. coli cells but failed because of the high A/T contents of these sequences. To overcome this difficulty, we identified the common sequence features of the centromere of Plasmodium spp. and designed a small centromere that retained those features. The centromere plasmid constructed with the small centromere sequence, pFCEN, segregated into daughter parasites with approximately 99% efficiency, resulting in the stable maintenance of this plasmid in P. falciparum even in the absence of drug selection. This result demonstrated that the small centromere sequence harboured in pFCEN could function as an actual centromere in P. falciparum. In addition, transgenic parasites were more rapidly generated when using pFCEN than when using the control plasmid, which did not contain the centromere sequence. Furthermore, in contrast to the control plasmid, pFCEN did not form concatemers and, thus, was maintained as a single copy over multiple cell divisions. These unique properties of the pFCEN plasmid will solve the current technical limitations of the genetic manipulation of P. falciparum, and thus, this plasmid will become a standard genetic tool for the study of this parasite